These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23536208)

  • 21. Fabrication of biocleavable shell cross-linked hybrid micelles for controlled drug release using a reducible silica monomer.
    Zhang X; Zhang X; Sun L; Liu F; Wang M; Peng J; Wang Y; Ma L; Wang B; Wei H
    Chem Commun (Camb); 2018 Nov; 54(96):13495-13498. PubMed ID: 30345448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles.
    Barbieri S; Buttini F; Rossi A; Bettini R; Colombo P; Ponchel G; Sonvico F; Colombo G
    Int J Pharm; 2015 Aug; 491(1-2):99-104. PubMed ID: 26095916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.
    Shen J; He Q; Gao Y; Shi J; Li Y
    Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J; Chen XG; Li YY; Liu CS
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin.
    Chuah AM; Kuroiwa T; Ichikawa S; Kobayashi I; Nakajima M
    J Food Sci; 2009; 74(1):N1-8. PubMed ID: 19200109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(styrene oxide)-poly(ethylene oxide) block copolymers: From "classical" chemotherapeutic nanocarriers to active cell-response inducers.
    Cambón A; Rey-Rico A; Barbosa S; Soltero JF; Yeates SG; Brea J; Loza MI; Alvarez-Lorenzo C; Concheiro A; Taboada P; Mosquera V
    J Control Release; 2013 Apr; 167(1):68-75. PubMed ID: 23352909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride.
    Vrignaud S; Hureaux J; Wack S; Benoit JP; Saulnier P
    Int J Pharm; 2012 Oct; 436(1-2):194-200. PubMed ID: 22721853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
    Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
    J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery.
    Pan Z; Gao Y; Heng L; Liu Y; Yao G; Wang Y; Liu Y
    Carbohydr Polym; 2013 Apr; 94(1):394-9. PubMed ID: 23544554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
    Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
    J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation conditions optimization of Epimedium polysaccharide liposome].
    Gao H; Gao Q; Wang DY; Fan YP; Guo LW; Zhao XN
    Zhong Yao Cai; 2011 Sep; 34(9):1429-33. PubMed ID: 22260012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encapsulation of an adamantane-doxorubicin prodrug in pH-responsive polysaccharide capsules for controlled release.
    Luo GF; Xu XD; Zhang J; Yang J; Gong YH; Lei Q; Jia HZ; Li C; Zhuo RX; Zhang XZ
    ACS Appl Mater Interfaces; 2012 Oct; 4(10):5317-24. PubMed ID: 23009157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy.
    Starkewolf ZB; Miyachi L; Wong J; Guo T
    Chem Commun (Camb); 2013 Mar; 49(25):2545-7. PubMed ID: 23423224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
    Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dry powder inhaler formulation of lipid-polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles.
    Yang Y; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Sep; 434(1-2):49-58. PubMed ID: 22634138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
    He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
    Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaempferol loaded lecithin/chitosan nanoparticles: preparation, characterization, and their potential applications as a sustainable antifungal agent.
    Ilk S; Saglam N; Özgen M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):907-916. PubMed ID: 27265551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.